Open AccessSurvivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine
Author(s) -
Ryan N. Fuller,
Janviere Kabagwira,
Paul Vallejos,
Andrew D Folkerts,
Nathan R. Wall
Publication year - 2022
Publication title -
oncotargets and therapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s341720
Subject(s) - survivin , gene knockdown , gemcitabine , cancer research , alternative splicing , oxaliplatin , irinotecan , splice , rna splicing , cell culture , cancer , biology , medicine , gene isoform , gene , colorectal cancer , genetics , rna
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom